NSI-189 Phosphate
CAS No. 1270138-41-4
NSI-189 Phosphate ( NSI189 Phosphate,NSI 189 Phosphate,NSI-189 Phosphate )
Catalog No. M22720 CAS No. 1270138-41-4
NSI-189 Phosphate is a novel neurogenic molecule with pleiotropic properties, including antidepressant, procognitive, synaptoplastic, and neurotrophic activities demonstrated in preclinical studies.?Its antidepressant activity is monoamine-independent.NSI-189 actively stimulated remodeling of the stroke brain.?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
|
10MG | 68 | In Stock |
|
25MG | 115 | In Stock |
|
50MG | 173 | In Stock |
|
100MG | 258 | In Stock |
|
200MG | 388 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNSI-189 Phosphate
-
NoteResearch use only, not for human use.
-
Brief DescriptionNSI-189 Phosphate is a novel neurogenic molecule with pleiotropic properties, including antidepressant, procognitive, synaptoplastic, and neurotrophic activities demonstrated in preclinical studies.?Its antidepressant activity is monoamine-independent.NSI-189 actively stimulated remodeling of the stroke brain.?
-
DescriptionNSI-189 Phosphate is a novel neurogenic molecule with pleiotropic properties, including antidepressant, procognitive, synaptoplastic, and neurotrophic activities demonstrated in preclinical studies.?Its antidepressant activity is monoamine-independent.NSI-189 actively stimulated remodeling of the stroke brain.?Parallel in vitro studies further probed this remodeling process and demonstrated that oxygen glucose deprivation and reperfusion (OGD/R) initiated typical cell death processes, which were reversed by NSI-189 treatment characterized by significant attenuation of OGD/R-mediated hippocampal cell death and increased Ki67 and MAP2 expression, coupled with upregulation of neurogenic factors such as BDNF and SCF.?These findings support the use of oral NSI-189 as a therapeutic agent well beyond the initial 6-hr time window to accelerate and enhance the overall functional improvement in the initial 6 months post stroke.
-
SynonymsNSI189 Phosphate,NSI 189 Phosphate,NSI-189 Phosphate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1270138-41-4
-
Formula Weight464.5
-
Molecular FormulaC22H33N4O5P
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESOP(O)(O)=O.CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tajiri N , Quach D M , Kaneko Y , et al. NSI‐189, a small molecule with neurogenic properties, exerts behavioral, and neurostructural benefits in stroke rats[J]. Journal of Cellular Physiology, 2017.
molnova catalog
related products
-
TC-A 2317 hydrochlor...
TC-A 2317 hydrochloride is an inhibitor of Aurora kinase A with a Ki of 1.2 nM compared to Aurora kinase B with a Ki of 101 nM. TC-A 2317 hydrochloride shows antitumor activity.
-
Valganciclovir hydro...
Valganciclovir (hydrochloride), the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir.
-
PAT-1251
PAT-1251 (PAT 1251, PAT1251) is apotent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays.